Reviva Pharmaceuticals I... (RVPH)
NASDAQ: RVPH
· Real-Time Price · USD
0.35
-0.41 (-54.17%)
At close: Jun 26, 2025, 3:59 PM
Reviva Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -2.4 | -1.45 | -1.16 | -3.4 | -3.65 | -2.79 | -2.64 | -3.46 | -2.68 | -2.18 | -0.95 | -1.54 | -2.83 | -8.24 | -9.73 | -13.96 |
PEG Ratio | 0.06 | 0.39 | -0.34 | 0.12 | 0.19 | 0.13 | -0.03 | 0.15 | -0.02 | 0.06 | 0.03 | -0.03 | -0.03 | 7.35 | -0.45 | 0.35 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 73.84 | -4.88 | -6.02 | -75.06 | 24.82 | -13.77 | 81.09 | 15.81 | 7.06 | 1.50 | 1.26 | 2.13 | 1.45 | 2.33 | 1.81 | 11.73 |
P/FCF Ratio | -6.59 | -11.48 | -4.29 | -8.62 | -15.99 | -18.98 | -24.72 | -11.51 | -18.53 | -7.66 | -5.08 | -7.25 | -10.69 | -32.53 | -46.67 | -17 |
P/OCF Ratio | -6.59 | -11.48 | -4.29 | -8.62 | -15.99 | -18.98 | -24.72 | -11.51 | -18.53 | -7.66 | -5.08 | -7.25 | -10.69 | -32.53 | -46.67 | -17 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.56 | -0.01 | -0.03 | -0.25 | n/a | -0.03 | 0.14 | 0.12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 1.01 | 0.39 | 0.52 | 0.93 | 1.38 | 0.41 | 1.29 | 1.97 | 3.13 | 6.72 | 4.61 | 6.97 | 13.39 | 34.81 | 31.42 | 6.04 |
Current Ratio | 1.01 | 0.39 | 0.52 | 0.93 | 1.38 | 0.41 | 1.29 | 1.97 | 3.13 | 6.72 | 4.61 | 6.97 | 13.39 | 34.81 | 31.42 | 6.04 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -1.33K | -1.64K | -1.58K | -2.27K | 489.30 | -1.81K | -946.04 | -879.89 | -58.32 | -71.97 | -718.31 | -32.11K | n/a | -4.53K | -504.4 | n/a |
Return on Equity | -7.7 | 0.84 | 1.30 | 5.52 | -1.7 | 1.23 | -7.68 | -1.14 | -0.66 | -0.17 | -0.33 | -0.34 | -0.13 | -0.07 | -0.05 | -0.21 |
Return on Assets | -0.4 | -1.1 | -0.98 | -0.55 | -0.41 | -1.95 | -1.05 | -0.51 | -0.43 | -0.15 | -0.26 | -0.29 | -0.12 | -0.07 | -0.04 | -0.14 |
Return on Invested Capital | -4.63 | 0.86 | 1.43 | 11.95 | -1.53 | 1.44 | -4.23 | -0.96 | -0.02 | -0.17 | -0.34 | -0.34 | -0.12 | -0.08 | -0.05 | -0.34 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |